查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970981

菸鹼醯胺市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區和競爭格局分類，2021-2031年

Niacinamide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球菸鹼醯胺市場預計將從 2025 年的 7.1523 億美元成長到 2031 年的 9.4487 億美元，複合年成長率為 4.75%。

菸鹼醯胺（也稱為尼克醯胺）是一種水溶性維生素B3，廣泛應用於製藥、藥用化妝品和動物營養領域。市場成長的主要驅動力是全球對有效護膚成分（可促進皮膚屏障修復和抗衰老齡化）的需求不斷成長，以及牲畜飼料中對代謝補充劑的迫切需求。個人護理產業的強勁成長支撐了這一需求；根據歐洲化妝品協會（Cosmetics Europe）預測，到2024年，歐洲化妝品和個人護理市場零售額預計將達到1,040億歐元，其中僅護膚類就將創造301億歐元的銷售額。

市場概覽
預測期 2027-2031
市場規模：2025年 7.1523億美元
市場規模：2031年 9.4487億美元
複合年成長率：2026-2031年 4.75%
成長最快的細分市場 液體
最大的市場 北美洲

儘管市場商業性勢頭強勁，但關鍵原料價格波動仍構成重大障礙。例如，3-氰基吡啶等關鍵前驅物的成本和供應波動威脅著生產的穩定性，並可能擠壓生產商的利潤空間。供應鏈的這種不確定性使長期策略規劃變得複雜，並可能阻礙全球菸鹼醯胺供應網路的持續擴張。

市場促進因素

菸鹼醯胺市場的主要商業性驅動力是消費者對抗老化和色素沉澱治療需求的不斷成長。由於其經臨床驗證的功效，例如增強皮膚屏障功能和減少色素沉著，菸鹼醯胺在皮膚科配方中越來越受歡迎。主要產業參與者的財務表現也印證了這一趨勢；根據歐萊雅於2024年2月發布的2023年度報告，該公司皮膚科化妝品部門的銷售額同比成長28.4%，反映出消費者對高效護膚的強烈偏好。皮膚科化妝品領域的擴張直接推動了高級產品對高純度菸鹼醯胺的需求，而拜爾斯道夫於2024年2月發布的2023年度報告也支持了這一趨勢。報告顯示，消費者業務部門的有機銷售額成長了12.5%。

同時，菸鹼醯胺在動物營養和牲畜飼料添加劑中的應用日益廣泛，對市場產生了顯著影響。除了化妝品應用外，維生素B3對家禽、豬和乳牛的代謝健康至關重要，持續產生穩定的產業規模訂單，並穩定供應鏈。該行業依賴複合飼料的持續生產來滿足全球蛋白質需求。根據Alltek於2024年2月發布的《2024年農業食品展望》，全球飼料產量預計將達到12.9億噸，凸顯了業界對必需添加劑的龐大需求。在如此龐大的規模下，穩定充足的菸鹼醯胺供應對於預防營養缺乏症、確保牲畜的最佳生長至關重要，從而建立起穩固的產業基礎，抵消化妝品產業的波動性。

市場挑戰

關鍵原料，尤其是3-氰基吡啶等重要前驅物的價格波動，對全球菸鹼醯胺市場構成重大挑戰。這些快速的成本變化導致生產者面臨不穩定的財務環境，直接影響利潤率，並使長期資本配置變得複雜。這些化學中間體價格的意外上漲導致生產商營運成本上升，而這些成本難以轉嫁給對價格敏感的醫藥和藥用化妝品行業的客戶。因此，用於市場擴張和創新的資金受到限制。

這種不穩定性因難以預測的全球供應鏈而進一步加劇，使市場面臨貿易流量和關稅不確定性。這種衝擊迫使企業優先考慮短期庫存管理，而非策略性成長措施。根據中國醫藥保健品進出口商會預測，在當前複雜的貿易環境下，包括菸鹼醯胺產品在內的保健食品出口額在2024年達到42.8億美元。這種不穩定的商業環境使供應鏈網路規劃更加複雜，並阻礙了製造商維持穩定生產水平，而這對於支撐市場穩定發展至關重要。

市場趨勢

頭髮和頭皮護理的「護膚化」代表著一種變革性的轉變，即以與臉部皮膚同等嚴謹的態度對待頭皮健康，這直接拓展了煙醯胺的應用範圍。這一趨勢正推動菸鹼醯胺被添加到高階洗髮精和頭皮精華液中，以發揮其促進角蛋白合成和強化脂質屏障抵禦環境壓力的能力。製造商越來越重視這些臨床功效——從根本上改善發炎和保濕——從而為維生素B3創造了一個新的高價值類別。這種以頭皮為中心的創新正在帶來可衡量的商業性成功。根據聯合利華於2024年2月發布的“2023會計年度業績報告”，該公司旗下Clear品牌實現了中等成長，這主要得益於一款含有高濃度煙醯胺的新型去屑配方，該配方可修復頭皮屏障。

同時，菸鹼醯胺融入極簡男士護理系列產品，正在拓展市場，吸引那些尋求高效多功能產品的消費者。該領域的產品研發優先考慮多功能活性成分，這些成分能夠在簡化的護膚步驟中有效控制油脂分泌、收縮毛孔並緩解剃須後的刺激。菸鹼醯胺的抗發炎和皮脂調節特性使其成為這些複雜產品的理想基底，推動著產業從傳統的刮鬍泡轉向全面的皮膚健康解決方案。這種對先進護理技術的需求也反映在近期的財務表現中。根據寶潔公司於2024年8月發布的《2024年年度報告》，公司護理部門的淨銷售額年增7%，凸顯了消費者對採用此類多功能活性成分的高階創新日常護理產品日益成長的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球菸鹼醯胺市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（粉末、液體、其他）
    • 按最終使用者（人類營養、藥品、動物營養、藥妝品、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美菸鹼醯胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲菸鹼醯胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區菸鹼醯胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲菸鹼醯胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：菸鹼醯胺在南美洲的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球菸鹼醯胺市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BASF
  • Lonza
  • Ashland
  • Shandong Xinchang
  • Jubilant Ingrevia
  • DSM
  • Hebei Welcome
  • Zhejiang Medicine
  • Evonik Industries
  • Foodchem International Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25489

The Global Niacinamide Market is projected to increase from USD 715.23 Million in 2025 to USD 944.87 Million by 2031, registering a CAGR of 4.75%. Niacinamide, a water-soluble form of Vitamin B3 also known as nicotinamide, is extensively utilized across the pharmaceutical, cosmeceutical, and animal nutrition sectors. Market growth is primarily sustained by the escalating global demand for active skincare ingredients that facilitate barrier repair and anti-aging, alongside the essential need for metabolic supplements in livestock feed. The strength of the personal care sector underpins this demand; according to Cosmetics Europe, the European cosmetics and personal care market reached a retail sales value of €104 billion in 2024, with the skin care category alone generating €30.1 billion.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 715.23 Million
Market Size 2031USD 944.87 Million
CAGR 2026-20314.75%
Fastest Growing SegmentLiquid
Largest MarketNorth America

Despite this positive commercial momentum, the market faces a substantial obstacle regarding the price volatility of critical raw materials. Fluctuations in the cost and availability of key precursors, such as 3-cyanopyridine, threaten manufacturing stability and compress profit margins for producers. This unpredictability within the supply chain complicates long-term strategic planning and may hinder the consistent expansion of the global niacinamide supply network.

Market Driver

A primary commercial catalyst for the niacinamide market is the rising consumer demand for treatments addressing anti-aging and hyperpigmentation. The ingredient is increasingly favored in dermatological formulations for its proven clinical ability to enhance skin barrier function and minimize discoloration. This trend is corroborated by the financial performance of major industry players; according to L'Oreal's '2023 Annual Report' published in February 2024, their Dermatological Beauty division saw like-for-like sales growth of 28.4%, reflecting a strong consumer preference for efficacy-driven skincare. This expansion in the dermocosmetics sector directly boosts the procurement of high-purity niacinamide for premium products, a trend further supported by Beiersdorf's 'Annual Report 2023' from February 2024, which reported organic sales growth of 12.5% in their Consumer Business Segment.

Simultaneously, the market is significantly influenced by the growing incorporation of niacinamide in animal nutrition and livestock feed additives. Beyond cosmetic uses, Vitamin B3 is vital for metabolic health in poultry, swine, and dairy cattle, driving consistent, industrial-volume orders that stabilize the supply chain. This segment relies on continuous compound feed production to meet global protein requirements. According to Alltech's '2024 Agri-Food Outlook' released in February 2024, global feed production volumes reached 1.29 billion metric tons, highlighting the massive industrial necessity for essential additives. This scale requires a steady, high-volume inflow of niacinamide to prevent deficiency diseases and ensure optimal livestock growth, creating a solid industrial foundation that counterbalances the volatility of the cosmetic sector.

Market Challenge

The price volatility of key raw materials, particularly essential precursors like 3-cyanopyridine, represents a major hurdle for the Global Niacinamide Market. These sharp cost fluctuations create a precarious financial environment for manufacturers, directly squeezing profit margins and complicating long-term capital allocation. When the prices of these chemical intermediates rise unexpectedly, producers face higher operational costs that are difficult to pass on to price-sensitive clients in the pharmaceutical and cosmeceutical sectors, thereby limiting the funds available for market expansion and innovation.

This instability is further exacerbated by the unpredictability of the global supply chain, which exposes the market to erratic trade flows and tariff uncertainties. Such disruptions force companies to prioritize short-term inventory management over strategic growth initiatives. According to the China Chamber of Commerce for Import & Export of Medicines & Health Products, the export value of China's health foods-a category including niacinamide products-reached $4.28 billion in 2024 amidst these complex trade dynamics. This volatile commercial landscape complicates supply network planning and prevents manufacturers from maintaining the consistent output levels needed to support steady market development.

Market Trends

The "skinification" of hair and scalp care signifies a transformative shift where scalp health is approached with the same rigor as facial skin, directly broadening the application scope of niacinamide. This trend drives the inclusion of the ingredient in premium shampoos and scalp serums, leveraging its capacity to boost keratin synthesis and strengthen the lipid barrier against environmental stressors. Manufacturers are increasingly emphasizing these clinical benefits to address inflammation and moisture retention at the root, creating a new high-value category for Vitamin B3. This focus on scalp-centric innovation is generating measurable commercial success; according to Unilever's 'Full Year 2023 Results' from February 2024, their Clear brand achieved mid-single digit growth, driven by a new anti-dandruff formula featuring a niacinamide concentrate for scalp barrier repair.

Concurrently, the integration of niacinamide into men's minimalist grooming lines is expanding the market to consumers seeking efficient, multi-functional products. Formulations in this segment now prioritize versatile active ingredients that manage excess sebum, pore size, and post-shave irritation within simplified regimens. Niacinamide's anti-inflammatory and oil-regulating properties make it an ideal cornerstone for these hybrid products, fueling the sector's evolution from traditional shaving foams to comprehensive skin health solutions. This demand for advanced grooming innovation is reflected in recent financial performance; according to Procter & Gamble's '2024 Annual Report' from August 2024, the company's Grooming segment saw a net sales increase of 7% over the prior year, underscoring the growing appetite for premium, innovation-led daily care products utilizing such multifunctional actives.

Key Market Players

  • BASF
  • Lonza
  • Ashland
  • Shandong Xinchang
  • Jubilant Ingrevia
  • DSM
  • Hebei Welcome
  • Zhejiang Medicine
  • Evonik Industries
  • Foodchem International Corporation

Report Scope

In this report, the Global Niacinamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Niacinamide Market, By Type

  • Powder
  • Liquid
  • Others

Niacinamide Market, By End User

  • Human Nutrition
  • Pharmaceuticals
  • Animal Nutrition
  • Cosmeceuticals
  • Others

Niacinamide Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Niacinamide Market.

Available Customizations:

Global Niacinamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Niacinamide Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Powder, Liquid, Others)
    • 5.2.2. By End User (Human Nutrition, Pharmaceuticals, Animal Nutrition, Cosmeceuticals, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Niacinamide Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Niacinamide Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Niacinamide Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Niacinamide Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Niacinamide Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Niacinamide Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Niacinamide Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Niacinamide Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Niacinamide Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Niacinamide Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Niacinamide Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Niacinamide Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Niacinamide Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Niacinamide Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Niacinamide Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Niacinamide Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Niacinamide Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Niacinamide Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Niacinamide Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Niacinamide Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. South America Niacinamide Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Niacinamide Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Niacinamide Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Niacinamide Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Niacinamide Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Lonza
  • 15.3. Ashland
  • 15.4. Shandong Xinchang
  • 15.5. Jubilant Ingrevia
  • 15.6. DSM
  • 15.7. Hebei Welcome
  • 15.8. Zhejiang Medicine
  • 15.9. Evonik Industries
  • 15.10. Foodchem International Corporation

16. Strategic Recommendations

17. About Us & Disclaimer